ALLMedicine™ Cholangiocarcinoma Center
Research & Reviews 8,981 results
https://doi.org/10.1136/gutjnl-2020-322983
Gut Goeppert B, Stichel D et. al.
Jan 20th, 2021 - A detailed understanding of the molecular alterations in different forms of cholangiocarcinogenesis is crucial for a better understanding of cholangiocarcinoma (CCA) and may pave the way to early diagnosis and better treatment options. We analysed...
https://doi.org/10.1007/s00432-021-03524-7 10.1200/JCO.2014.60.2219 10.1200/EDBK_160831 10.1016/j.ejso.2006.09.033 10.1056/NEJM199910283411807 10.1200/JCO.18.00050 10.1200/JCO.2013.49.5283 10.1016/j.jamcollsurg.2015.09.005 10.1200/JOP.18.00558 10.3748/wjg.v22.i8.2601 10.1002/cncr.11699 10.1007/s00268-016-3551-9 10.1016/j.semradonc.2018.06.003 10.1016/j.surg.2017.08.011 10.1002/jso.24836 10.1177/000313481207800440 10.1007/s00595-016-1354-0 10.1245/s10434-018-6388-7 10.1016/S1470-2045(18)30915-X 10.1200/JCO.18.02178
Journal of Cancer Research and Clinical Oncology; Im JH, Choi GH et. al.
Jan 20th, 2021 - The objective of this study was to investigate the benefits of adjuvant treatment for patients with resected perihilar cholangiocarcinoma (PHC). Between 2001 and 2017, 196 patients with PHC adenocarcinoma underwent curative resection. The patients...
https://doi.org/10.1007/s00595-020-02208-y 10.1097/00000658-200110000-00010 10.1056/NEJM199910283411807 10.1038/nrclinonc.2017.157 10.1016/S0168-8278(02)00297-0 10.1136/gut.48.6.816 10.1007/s11605-013-2251-0 10.1002/cncr.24766 10.1001/archsurg.136.2.209 10.1002/bjs.9367 10.1097/01.sla.0000150166.94732.88 10.1016/j.surg.2004.10.008 10.1007/s00595-018-1704-1 10.1007/978-3-319-40618-3 10.1016/j.ijgo.2013.10.001 10.1016/j.gassur.2006.07.013 10.1016/j.surg.2019.06.023 10.1016/S1072-7515(01)01065-1 10.1007/s00535-010-0298-1 10.14701/kjhbps.2011.15.3.179 10.5009/gnl14243 10.1245/s10434-015-4618-9 10.1007/s00535-015-1140-6 10.1007/s11605-017-3492-0 10.1056/NEJMoa0908721 10.1097/SLA.0b013e3181b0fc8b 10.1002/bjs.10776 10.1016/S1470-2045(18)30915-X
Surgery Today; Sumiyoshi T, Uemura K et. al.
Jan 20th, 2021 - The clinical importance of peritoneal washing cytology (PWC) for cholangiocarcinoma patients remains unclear. The clinical data of 137 extrahepatic cholangiocarcinoma patients who received PWC and curative surgery were retrospectively analyzed. Am...
https://doi.org/10.18632/aging.202446
Aging Xie X, Wang Y et. al.
Jan 20th, 2021 - Cholangiocarcinoma (CCA) is a fatal disease with dismal survival rates. Long non-coding RNA (lncRNA) expression profiling as potential prognostic biomarkers play critical roles in tumor initiation, development, and poor prognosis. Identifying spec...
https://doi.org/10.1002/jhbp.896
Journal of Hepato-biliary-pancreatic Sciences; Hara T, Eguchi S et. al.
Jan 19th, 2021 - Intrahepatic cholangiocarcinoma had been considered a contraindication for liver transplantation because of poorer outcomes. However, incidental intrahepatic cholangiocarcinoma in the explanted liver has been reported because of the difficulty of ...
Guidelines 15 results
https://doi.org/10.1016/j.cgh.2019.07.011
Clinical Gastroenterology and Hepatology : the Official C... Bowlus CL, Lim JK et. al.
Jul 15th, 2019 - The purpose of this clinical practice update is to define key principles in the surveillance of hepatobiliary cancers including cholangiocarcinoma, gallbladder adenocarcinoma, and hepatocellular carcinoma in patients with primary sclerosing cholan...
http://ascopubs.org/doi/full/10.1200/JCO.18.02178
Mar 10th, 2019 - PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with resected biliary tract cancer. METHODS ASCO convened an Expert Panel to conduct a systematic review of the literature on adju...
https://doi.org/10.1002/jhbp.596
Journal of Hepato-biliary-pancreatic Sciences; Kamisawa T, Nakazawa T et. al.
Dec 23rd, 2018 - IgG4-related sclerosing cholangitis (IgG4-SC) is a distinct type of cholangitis frequently associated with autoimmune pancreatitis and currently recognized as a biliary manifestation of IgG4-related disease. Although clinical diagnostic criteria o...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527854
HPB : the Official Journal of the International Hepato Pa... Mansour JC, Aloia TA et. al.
Jul 14th, 2015 - An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus meeting of expert panellists met on 15 January 2014 to review current evidence on the management of hilar cholangiocarcinoma in order to establish practice guidelines and...
https://doi.org/10.1111/jgh.12128
Journal of Gastroenterology and Hepatology; Rerknimitr R, Angsuwatcharakon P et. al.
Jan 28th, 2013 - Hilar cholangiocarcinoma (HCCA) is one of the most common types of hepatobiliary cancers reported in the world including Asia-Pacific region. Early HCCA may be completely asymptomatic. When significant hilar obstruction develops, the patient prese...
Drugs 2 results see all →
Clinicaltrials.gov 9,143 results
https://doi.org/10.1136/gutjnl-2020-322983
Gut Goeppert B, Stichel D et. al.
Jan 20th, 2021 - A detailed understanding of the molecular alterations in different forms of cholangiocarcinogenesis is crucial for a better understanding of cholangiocarcinoma (CCA) and may pave the way to early diagnosis and better treatment options. We analysed...
https://doi.org/10.1007/s00432-021-03524-7 10.1200/JCO.2014.60.2219 10.1200/EDBK_160831 10.1016/j.ejso.2006.09.033 10.1056/NEJM199910283411807 10.1200/JCO.18.00050 10.1200/JCO.2013.49.5283 10.1016/j.jamcollsurg.2015.09.005 10.1200/JOP.18.00558 10.3748/wjg.v22.i8.2601 10.1002/cncr.11699 10.1007/s00268-016-3551-9 10.1016/j.semradonc.2018.06.003 10.1016/j.surg.2017.08.011 10.1002/jso.24836 10.1177/000313481207800440 10.1007/s00595-016-1354-0 10.1245/s10434-018-6388-7 10.1016/S1470-2045(18)30915-X 10.1200/JCO.18.02178
Journal of Cancer Research and Clinical Oncology; Im JH, Choi GH et. al.
Jan 20th, 2021 - The objective of this study was to investigate the benefits of adjuvant treatment for patients with resected perihilar cholangiocarcinoma (PHC). Between 2001 and 2017, 196 patients with PHC adenocarcinoma underwent curative resection. The patients...
https://doi.org/10.1007/s00595-020-02208-y 10.1097/00000658-200110000-00010 10.1056/NEJM199910283411807 10.1038/nrclinonc.2017.157 10.1016/S0168-8278(02)00297-0 10.1136/gut.48.6.816 10.1007/s11605-013-2251-0 10.1002/cncr.24766 10.1001/archsurg.136.2.209 10.1002/bjs.9367 10.1097/01.sla.0000150166.94732.88 10.1016/j.surg.2004.10.008 10.1007/s00595-018-1704-1 10.1007/978-3-319-40618-3 10.1016/j.ijgo.2013.10.001 10.1016/j.gassur.2006.07.013 10.1016/j.surg.2019.06.023 10.1016/S1072-7515(01)01065-1 10.1007/s00535-010-0298-1 10.14701/kjhbps.2011.15.3.179 10.5009/gnl14243 10.1245/s10434-015-4618-9 10.1007/s00535-015-1140-6 10.1007/s11605-017-3492-0 10.1056/NEJMoa0908721 10.1097/SLA.0b013e3181b0fc8b 10.1002/bjs.10776 10.1016/S1470-2045(18)30915-X
Surgery Today; Sumiyoshi T, Uemura K et. al.
Jan 20th, 2021 - The clinical importance of peritoneal washing cytology (PWC) for cholangiocarcinoma patients remains unclear. The clinical data of 137 extrahepatic cholangiocarcinoma patients who received PWC and curative surgery were retrospectively analyzed. Am...
https://doi.org/10.18632/aging.202446
Aging Xie X, Wang Y et. al.
Jan 20th, 2021 - Cholangiocarcinoma (CCA) is a fatal disease with dismal survival rates. Long non-coding RNA (lncRNA) expression profiling as potential prognostic biomarkers play critical roles in tumor initiation, development, and poor prognosis. Identifying spec...
https://doi.org/10.1002/jhbp.896
Journal of Hepato-biliary-pancreatic Sciences; Hara T, Eguchi S et. al.
Jan 19th, 2021 - Intrahepatic cholangiocarcinoma had been considered a contraindication for liver transplantation because of poorer outcomes. However, incidental intrahepatic cholangiocarcinoma in the explanted liver has been reported because of the difficulty of ...
News 103 results
https://www.staging.medscape.com/viewarticle/928959
Apr 19th, 2020 - The US Food and Drug Administration (FDA) has granted accelerated approval of a new targeted therapy for use in some patients with cholangiocarcinoma, a rare cancer of the bile ducts. The product is pemigatinib (Pemazyre, Incyte), an oral kinase i...
https://www.medscape.com/viewarticle/928959
Apr 19th, 2020 - The US Food and Drug Administration (FDA) has granted accelerated approval of a new targeted therapy for use in some patients with cholangiocarcinoma, a rare cancer of the bile ducts. The product is pemigatinib (Pemazyre, Incyte), an oral kinase i...
https://reference.medscape.com/viewarticle/922403_1
Feb 19th, 2020 - Cancer of the bile duct, or cholangiocarcinoma, is a malignant neoplasm of the intrahepatic or extrahepatic biliary epithelium. It is the most common biliary tract cancer and the second most common primary hepatic cancer. Although its etiology is ...
https://reference.medscape.com/viewarticle/922403_2
Feb 19th, 2020 - Figure 1. Common bile duct and pancreatic duct Perihilar tumors, also called Klatskin tumors, are the most common cholangiocarcinomas. They occur in the hilum region at the bifurcation of the right and left hepatic ducts. Intrahepatic tumors are t...
https://reference.medscape.com/viewarticle/922398_3
Feb 19th, 2020 - Even though the rates of resection with tumor-free margins have improved with more aggressive surgical approaches and improved radiologic techniques, recurrence rates remain high (49%-64%). These recurrences usually occur within 2-3 years post-res...